
Stroke is the second leading cause of death [1,2] and third leading cause of disability adjusted life-years across the globe [3]. Stroke is one of the serious public health concerns. Possibly due to substantial increase in the modifiable and non-modifiable risk factors, India stands 2nd in having the highest rates of mortality and morbidity due to stroke [1]. Stroke affects every domain of an individual varying from motor, sensory, cognitive, perceptual, and psychological domains [4]. Among the constellation of symptoms, motor impairment is the most common, which affects the upper and lower extremities (UEs and LEs) in more than 88% of stroke victims [5]. Paresis, loss of fine motor skills and movement abnormalities together constitute the upper limb impairments of individuals affected by stroke, which accounts for 73%-88% in first time stroke survivors and 50% of chronic stroke survivors [6]. Difficulty in walking is another most common complaint of stroke survivors, making them dependent to a great extent [7].
Persistent disability following stroke impairs activities of daily living performance such as dressing, eating, self-care and personal hygiene etc. which underlies the strong need for the development of a novel neurorehabilitation approach considering the extent of injury and the amount of damage caused by it [8]. Despite the extensive efforts, functional recovery of an individual remains incomplete. Limited understanding of the process of recovery along with the constraints regarding time, lack of cost effectiveness, labour intensive techniques, lack of standardized procedures and lack of long-term adherence to the rehabilitation results in partial recovery [9,10].
Lack of optimal recovery has lead substantial drift of rehabilitation professionals towards the use of technology-aided electrical interventions in the form of transcranial direct current stimulation, utilizing reorganizing capacity of the brain to enhance the motor recovery following stroke. Extensive literature is available on the therapeutic benefits of transcranial direct current stimulation (tDCS) on the motor recovery of stroke. But most trials have targeted single areas of the cortex that were relevant to the specific deficits.
The brain is the hub of cortical connections. The areas of the brain are structurally and functionally related to each other. In the year 1949, Donald Hebb proposed the rule that “Neurons that fire together, wire together”. Hebb’s rule provided the theoretical base that homosynaptic and heterosynaptic activities facilitate synaptic formation and consolidation during motor rehabilitation [11].
Motor learning entails strong interaction with the cognitive domains like attention, planning, memory and execution control. Hence, the same principle can be applied while stimulating the neuromotor control system at more than one level thereby manipulating the corresponding neuronal circuits and better outcomes may be expected.
Undermentioned is the case of a subacutre stroke survivor intervened with multichannel transcranial direct current stimulation (M-tDCS) along with the peripheral stimulation techniques such as functional electrical stimulation (FES) and exoskeletal device (SaeboFlex; Saebo, Inc., Charlotte, NC, USA) and in which post intervention effects were notified.
A 50-year old male with a history of hypertension and type II diabetes came to the rehabilitation unit with the chief complaint of difficulty in performing activities of daily living and walking. Care givers of the patient reported his ease in forgetfulness of things and difficulty in recall of the things and experiences related to him. The patient had no significant tobacco, alcohol, or recreational drug use history. His past medical history was significant for peripheral neuropathy affecting his feet. The patient was conscious during the episode. There was no history of headache and vomiting and fall associated with episode of stroke. Within two hours on the day of episode, patient noticed clumsiness in his right hand which was soon followed by dragging of his right foot while walking. Within the next hour, slight drooping of the right side of his face and slurring of speech was also noticed and so the patient was admitted for medical management. No family history of previous episodes of stroke is associated with the patient. Computed tomography scans of the patient reflected hypodensity in the middle cerebral artery region and no signs of hemorrhage. Magnetic resonance imaging findings confirmed the diagnosis of ischemic infarct in the left middle cerebral artery territory.
Initial patient screeningInitial screening of the patient was done with a comprehensive neurological assessment format enclosing a detailed history of the patient, higher mental function assessment, motor examination, reflex examination, sensory assessment, cranial nerve assessment and gait examination with the aim to rule any absolute contraindications for tDCS and other therapeutic interventions.
The patient was oriented to person, place and time. His cognitive screening was done with the Mini-mental status examination (MMSE). His MMSE score was 18 depicting mild cognitive impairment. His spasticity was graded as 1+ for the right UE and LE, measured on the modified Ashworth scale, and his reflex assessment revealed exaggerated responses. No sensory deficits were found other than lack of propioceptive response. Motor examination revealed that the patient had preserved range of motion of approximately 10 degrees at the wrist joint. His facial nerve was found to be affected along with some hearing deficit on the paralytic side. Patient was ambulatory and was walking with the help of a walker. The patient had right facial droop, dysarthria and mild dysphagia.
The current patient was the participant of the trial (CTRI/2020/01/022998). Participant selection was done as per selection criteria of the trial. Inclusion criteria was male or female subacute stroke survivors within the age group of 50 to 80 years, Spasticity in the upper or lower extremities having a modified Ashworth scale score <2, those with preserved range of wrist extension (≈10 degrees), are able to walk, and individuals with mild cognitive impairment with a MMSE score of 18-23, and those willing to participate in the study. The exclusion criteria was individuals diagnosed with hemorrhagic stroke, with a history of neurological disease other than stroke, with a history of musculoskeletal injury/disease affecting the UE and LE, with the history of psychosomatic illness/disease, individuals having cardiovascular & respiratory problems, any systemic illness, individuals with metallic implants, individuals with a visual analog scale score of >4 for pain in the UE/LE, individuals participating in other pharmacological & rehabilitation studies during the study period, individuals with any sensory problems, or non-cooperative individuals.
Ethics and participant consentThe patient was a participant of this trial approved by Institutional ethics committee of Punjabi University (IRB No. 152/IEC-2019) and has also been registered with clinical trial registry of India (CTRI/2020/01/022998). An information sheet was given to the patient in which he was notified regarding objectives, procedure, interventions, potential risks and/or expected benefits of the intervention. A written consent was obtained prior to the intervention. The patient was ensured that his identity would be concealed.
Objective assessmentBaseline assessment was performed using the Fugl-Meyer assessment scale for the upper extremity and lower extremity FMA (UE and LE). The FMA is a multi-item, performance-based impairment index which evaluates balance, sensation and joint functioning in the individuals affected with stroke. FMA has excellent interrater and intrarater reliability and construct validity [12].
The Montreal Cognitive Assessment (MOCA) assesses the cognitive domains, namely attention, concentration, executive functioning, orientation, language, visuospatial skills and memory through performance of various independent tasks. MOCA has acceptable responsiveness and criterion validity in stroke patients [13,14].
The Wisconsin Gait Scale (WGS) constitutes a promising tool for a qualitative, observational analysis of gait in post-stroke individuals and allows for proper planning, monitoring and assessing rehabilitation results. WGS has a high internal consistency and test-retest reliability [15].
Stroke specific scale was used for objective measurement of gait and quality of life. Stroke Specific Quality of Life (SSQOL) measures the quality of life and is a standardized, reliable (reliability coefficient 0.92), validated scale that specifically measures the quality of life of individuals with stroke.
InterventionThe patient was intervened with M-tDCS over the left primary motor cortex PMC i.e. C3 point and left dorsolateral prefrontal cortex (L-DLPFC) i.e. F3 point with 0.5-2 mA intensity for a period of 20 minutes [12]. Points of stimulation were selected based on 10-20 electroencephalography international classification system. SaeboFlex assisted task oriented training [16,17] FES over the LE to elicit dorsiflexion at the ankle and eversion of the foot and conventional physiotherapy rehabilitation including a tailored exercise program [18]. Whole intervention was given for five times per week for a total of 4 weeks.
Mid and post-intervention assessment was done for all the outcome measures at day 15 and day 30 respectively in order to quantify the improvement of the patient. Patient improvement was observed in the motor and cognitive domains (Figure 1). Motor functions were found to be improved with the changes in the scores of FMA measured for the UE and LE. The FMA-UE score increased from 96 to 105 (Figure 2) and the FMA-LE scores increased from 55 to 67 (Figure 3). Similarly, improvement was also observed in the cognitive functions with a 10-point rise in MOCA scores from 8 to 18 (Figure 4). However, the patient still had difficulty in language comprehension and abstract thinking. The patient was ambulatory and was walking with the help of walker prior to the intervention. Improvement was also observed in his gait parameters with a reduction in WGS scores from 40.4 at day 0 to 25.85 at day 30.
Improvement was also observed in the overall quality of life of the patient. His language, mobility, energy, social domains and UE functions were significantly better post intervention with overall changes in SSQOL scores from 92 to 162 over the period of 4 weeks (Figure 5). As reported by patient and his caregivers, they found decreased level of dependency for his activities of daily living and increased interest in participation in his community activities (Table 1).
Noninvasive brain stimulation is an emerging neuromodulation method to induce brain plasticity. Among such methods, transcranial magnetic stimulation and tDCS are most commonly used in the field of basic neuroscience and clinical application. But, the present work is discrete in its implementation of the M-tDCS along with SaeboFlex, FES and conventional rehabilitation for a period of 4 weeks determining their effect on overall recovery in a subacute stroke survivor.
The theoretical underpinning for clinical applicability of M-tDCS on individuals with stroke, targeting motor as well as DLPFC was developed from the fact that both motor as well as cognitive impairments coexist in stroke survivors causing devastating effects on their quality of life. The association between motor and cognitive impairment after stroke was explored in a review study. Authors of the study concluded that motor and cognitive impairments after stroke were correlated, despite the heterogeneity in populations, designs and tasks used in the studies included in this review. The most consistent finding was that the disturbances of gait, balance and limb function were often accompanied by deficits in attention and executive function [19].
The idea behind the use of peripheral stimulation in the form of SaeboFlex training and FES was to increase the magnitude of facilitatory effects induced by M-tDCS. Motor functions were significantly improved by application of tDCS with physical and occupational therapy in a study conducted by Hoyer
Results in the current patient have been found to be analogous to a study conducted on patients with Parkinson disease in which multitarget transcranial direct current stimulation of the primary motor cortex and left dorsolateral prefrontal cortex induced immediate after effects in the brain that translate into reduced freezing episodes of gait and improvements in executive function and mobility. Dagan
Limitations
The findings of this study cannot be generalized since this is a single participant study and no comparison has been done in order to establish the efficacy of M-tDCS. However, an integrated approach of the M-tDCS has provided the add-on effect with respect to the improvement in motor as well as cognitive domains of the patient. Large sample trials are required to establish the effectiveness of M-tDCS in stroke survivors.
To conclude, the application of M-tDCS induced improvements in motor functions of the UE and LE, gait parameters and cognitive functions of the patient. The participant became an independent community ambulatory at a speed at least 50% of normal. This evidence will be crucial in designing better regimen, both in terms of content and context, of the rehabilitation process after stroke.
Department of Physiotherapy, Punjabi University for resource allocation and participant recruitment. Equipment support by Medicaid India.
The authors declared no potential conflicts of interest with respect to the authorship and/or publication of this article.
Improvement in FMA score during the intervention period
Outcome measure | Maximum score | Scores obtained | ||
---|---|---|---|---|
Day 0 | Day 15 | Day 30 | ||
FMA (UE) | 126 | 76 | 90 | 105 |
FMA (LE) | 86 | 55 | 61 | 67 |
WGS (score) | 42 | 40.4 | 37.8 | 25.85 |
MOCA (score) | 30 | 8 | 14 | 20 |
SSQOL (score) | 245 | 92 | 117 | 162 |
FMA (UE): Fugl-Meyer assessment for upper extremity, FMA (LE): Fugl-Meyer assessment for lower extremity, WGS: Wisconsin gait scale, MOCA: Montreal cognitive assessment, SSQOL: stroke specific quality of life.